Type-I Interferon is Critical for FasL Expression on Lung Cells to Determine the Severity of Influenza

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Fujikura, Daisuke ^a,b   Chiba, Satoko ^a   Muramatsu, Daisuke ^a,c   Kazumata, Mika ^a,c   Nakayama, Yosuke ^a   Kawai, Taro ^d,e   Akira, Shizuo ^d,e   Kida, Hiroshi ^a,b,f,g   Miyazaki, Tadaaki ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c Aureo Science Co Ltd   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

^g Centre collaborateur de l'Organisation mondiale de la santé animale   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DISEASE SEVERITY; FAS GENE; FASL GENE; GENE EXPRESSION; GENE MUTATION; INFLUENZA A; INTERFERON INDUCTION; INTERFERON PRODUCTION; LUNG ALVEOLUS CELL; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; SURVIVAL RATE;

ANIMALS; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; DNA PRIMERS; DOGS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; INTERFERON TYPE I; LUNG; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84873658862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055321     Document Type: Article

References (26)

1. Kohlmeier JE, Woodland DL, (2009) Immunity to Respiratory Viruses. Annual Review of Immunology 27: 61-82.
2. Strasser A, Jost PJ, Nagata S, (2009) The Many Roles of FAS Receptor Signaling in the Immune System. Immunity 30: 180-192.
3. Nagata S, Suda T, (1995) Fas and Fas ligand- Lpr and gld Mutations. Immunology Today 16: 39-43.
4. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
5. Fujimoto I, Takizawa T, Ohba Y, Nakanishi Y, (1998) Co-expression of Fas and Fas-ligand on the surface of influenza virus-infected cells. Cell Death and Differentiation 5: 426-431.
6. Legge KL, Braciale TJ, (2005) Lymph node dendritic cells control CD8(+) T cell responses through regulated FasL expression. Immunity 23: 649-659.
7. Matute-Bello G, Lee JS, Liles WC, Frevert CW, Mongovin S, et al. (2005) Fas-mediated acute lung injury requires Fas expression on nonmyeloid cells of the lung. Journal of Immunology 175: 4069-4075.
8. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, et al. (2001) Fas (CD95) induces alveolar epithelial cell apoptosis in vivo- Implications for acute pulmonary inflammation. American Journal of Pathology 158: 153-161.
9. Matute-Bello G, Liles WC, Frevert CW, Nakamura M, Ballman K, et al. (2001) Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. American Journal of Physiology-Lung Cellular and Molecular Physiology 281: L328-L335.
10. Sadler AJ, Williams BRG, (2008) Interferon-inducible antiviral effectors. Nature Reviews Immunology 8: 559-568.
11. Kato H, Takahasi K, Fujita T, (2011) RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunological Reviews 243: 91-98.
12. Kawai T, Akira S, (2011) Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity. Immunity 34: 637-650.
13. Honda K, Takaoka A, Taniguchi T, (2006) Type I inteferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
14. Huber JP, Farrar JD, (2011) Regulation of effector and memory T-cell functions by type I interferon. Immunology 132: 466-474.
15. Kaser A, Nagata S, Tilg H, (1999) Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine 11: 736-743.
16. Sivaraman V, Zhang L, Su L, (2011) Type I Interferon Contributes to CD4(+) T Cell Depletion Induced by Infection with HIV-1 in the Human Thymus. Journal of Virology 85: 9243-9246.
17. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 76: 969-976.
18. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, et al. (1994) The mouse fas-ligand gene is mutated in gld mice and is part of a tnf family gene-cluster. Immunity 1: 131-136.
19. Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S, (2002) Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. International Immunology 14: 1225-1231.
20. Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, et al. (2009) Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses. Plos Pathogens 5.
21. Isaacs JD, Greenwood J, Waldmann H, (1998) Therapy with monoclonal antibodies. II. The contribution of Fc gamma receptor binding and the influence of C(H)1 and C(H)3 domains on in vivo effector function. Journal of Immunology 161: 3862-3869.
22. Langlois RA, Legge KL, (2010) Plasmacytoid Dendritic Cells Enhance Mortality during Lethal Influenza Infections by Eliminating Virus-Specific CD8 T Cells. Journal of Immunology 184: 4440-4446.
23. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, et al. (2007) Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27: 240-252.
24. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD, (2008) CCR2(+) monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. Journal of Immunology 180: 2562-2572.
25. Taniguchi T, Takaoka A, (2001) A weak signal for strong responses: Interferon-alpha/beta revisited. Nature Reviews Molecular Cell Biology 2: 378-386.
26. Banchereau J, Pascual V, (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.